Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

PJ Publications

PJ Online content is produced by PJ Publications, part of Pharmaceutical Press, the publishing division of the Royal Pharmaceutical Society of Great Britain. All PJ publications are editorially independent of the Royal Pharmaceutical Society.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Springer Nature

Springer Nature

Did you know that we publish over 3,000 journals, and that over 1,000 of those are clinical science journals? Promote your approved branded drugs and medical devices to our audience…

View Profile

Advertising, Medical communications, Publishers

Streaming Well - Video For Healthcare

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Medical communications, Medical education, Publishers, Translation services

- PMLiVE

Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that we attend each year.

View Profile

Medical communications, Medical education, Publishers

Company Details

PJ Publications
1 Lambeth High Street, Lambeth, London, SE1 7JN, United Kingdom
+44 (0)20 7572 2222
Contact PJ Publications
Website

 Latest Content from PMHub 

How to connect HQ and affiliates with data-enriched content

White Papers and Resources | January 21, 2016 | Anthill Agency

Data should be the lifeblood of marketing: linking all parts of the organization and continually circulating knowledge and understanding.

Lucid’s digital responsibility: delivering value by improving patient outcomes

Press Releases | January 19, 2016 | Lucid Group Communications Limited

Digital initiatives must address your customer's needs

Why are we still talking about multichannel?

White Papers and Resources | January 19, 2016 | Anthill Agency

Interview with Sebastian Kölsch, Chief Solutions Officer at Anthill.

Key topics and trends for pharma and healthcare in 2016

White Papers and Resources | January 12, 2016 | Blue Latitude Health

Introducing PERSPECTIVE, the new digital magazine from Blue Latitude Health. A step beyond identifying top trends, this magazine explores key topics for 2016 for pharma and healthcare companies.

The art of managing digital communications from headquarters

White Papers and Resources | January 12, 2016 | Anthill Agency

Total control from headquarters or every market doing what they think is best?

2015 was avid for the avocado

White Papers and Resources | January 12, 2016 | Say Communications

In 2015 avocado trended across the media. One Say blogger wonders what PR lessons we can learn from this healthy fruit?

Lucid Group US: moving on up!

Press Releases | January 7, 2016 | Lucid Group Communications Limited

New premises for Lucid Group US

Research Partnership is UK’s fastest growing healthcare market research specialist

White Papers and Resources | January 6, 2016 | Inizio

The latest league tables for the UK market research industry have just been released and reveal Research Partnership to be the fastest growing healthcare market research specialist for 2014.With turnover...

Emerging Markets: Your Essential Guide

White Papers and Resources | January 6, 2016 | Inizio

Using our combined knowledge and years of experience of working in these territories, our experts have produced an essential guide to help address some of the core challenges for conducting market...

Free Thinking: From promise to practice: immuno-oncology in action

White Papers and Resources | January 6, 2016 | Inizio

This white paper explores the global outlook for new immunotherapy products, referencing key opinion leaders and payers to investigate how these products are faring both clinically and financially. Immuno-oncology therapies that...